QRX003 is under development as a potential therapy for the treatment of Netherton Syndrome (NS). The product is a once-daily topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare® delivery technology.   Netherton Syndrome (NS) Netherton Syndrome – a rare, hereditary skin disorder – is an autosomal recessive genetic disease caused by a mutation in the […]


QRX007 is a bi-functional protein designed to be highly selective and potent inhibitor of the KLK5 and KLK7 kallikreins at nanomolar concentrations as a potential treatment for Netherton Syndrome. Netherton syndrome (NS) is an autosomal recessive skin disorder with severe skin inflammation, scaling, constant allergy and specific hair defection. NS is caused by dysfunctional mutations […]